Mary Kay Fenton

Achillion Pharmaceuticals

Former Executive Vice President, Chief Financial Officer and Treasurer

Overview

Mary Kay Fenton made an average of $916.5K in compensation at Achillion Pharmaceuticals from 2008 to 2018.

Annual data

2018

In 2018, Mary Kay Fenton earned a total compensation of $1.1M as Former Executive Vice President, Chief Financial Officer and Treasurer at Achillion Pharmaceuticals.

Ranking5,816 out of 8,692
Percentile33.1%

Mary Kay Fenton's 2018 compensation ranked 5,816th out of 8,692 executive pay records tracked by us this year.

Fenton earned more than 33.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking437 out of 614
Percentile28.8%

In the industry group of Drugs, Fenton's pay ranked 437th out of 614 executive pay records tracked by us in 2018.

Fenton earned more than 28.8% of executives in this group.

Option Awards$505,000
Salary$382,130
Other$195,762
Total$1,082,892

Fenton received $505K in option awards, which accounts for 46.63% of total compensation.

Fenton also received $382.1K in salary and $195.8K in other compensation.

2017

In 2017, Mary Kay Fenton earned a total compensation of $991.9K as Former Executive Vice President, Chief Financial Officer and Treasurer at Achillion Pharmaceuticals.

Ranking8,224 out of 13,224
Percentile37.8%

Mary Kay Fenton's 2017 compensation ranked 8,224th out of 13,224 executive pay records tracked by us this year.

Fenton earned more than 37.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking805 out of 1,405
Percentile42.7%

In the industry group of Drugs, Fenton's pay ranked 805th out of 1,405 executive pay records tracked by us in 2017.

Fenton earned more than 42.7% of executives in this group.

Non-Equity Incentive Plan$120,218
Option Awards$481,043
Salary$382,130
Other$8,557
Total$991,948

Fenton received $481K in option awards, which accounts for 48.49% of total compensation.

Fenton also received $120.2K in non-equity incentive plan, $382.1K in salary and $8.6K in other compensation.

2016

In 2016, Mary Kay Fenton earned a total compensation of $1.1M as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals.

Ranking7,598 out of 13,877
Percentile45.2%

Mary Kay Fenton's 2016 compensation ranked 7,598th out of 13,877 executive pay records tracked by us this year.

Fenton earned more than 45.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking720 out of 1,472
Percentile51.1%

In the industry group of Drugs, Fenton's pay ranked 720th out of 1,472 executive pay records tracked by us in 2016.

Fenton earned more than 51.1% of executives in this group.

Non-Equity Incentive Plan$101,932
Option Awards$635,350
Salary$371,000
Other$8,310
Total$1,116,592

Fenton received $635.4K in option awards, which accounts for 56.90% of total compensation.

Fenton also received $101.9K in non-equity incentive plan, $371K in salary and $8.3K in other compensation.

2015

In 2015, Mary Kay Fenton earned a total compensation of $527.9K as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals.

Ranking10,586 out of 13,574
Percentile22.0%

Mary Kay Fenton's 2015 compensation ranked 10,586th out of 13,574 executive pay records tracked by us this year.

Fenton earned more than 22.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,195 out of 1,484
Percentile19.5%

In the industry group of Drugs, Fenton's pay ranked 1,195th out of 1,484 executive pay records tracked by us in 2015.

Fenton earned more than 19.5% of executives in this group.

Non-Equity Incentive Plan$159,452
Salary$360,140
Other$8,298
Total$527,890

Fenton received $360.1K in salary, which accounts for 68.22% of total compensation.

Fenton also received $159.5K in non-equity incentive plan and $8.3K in other compensation.

2014

In 2014, Mary Kay Fenton earned a total compensation of $1.7M as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals.

Ranking5,131 out of 12,876
Percentile60.2%

Mary Kay Fenton's 2014 compensation ranked 5,131st out of 12,876 executive pay records tracked by us this year.

Fenton earned more than 60.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking451 out of 1,310
Percentile65.6%

In the industry group of Drugs, Fenton's pay ranked 451st out of 1,310 executive pay records tracked by us in 2014.

Fenton earned more than 65.6% of executives in this group.

Non-Equity Incentive Plan$158,479
Option Awards$1,209,436
Salary$347,679
Other$8,124
Total$1,723,718

Fenton received $1.2M in option awards, which accounts for 70.16% of total compensation.

Fenton also received $158.5K in non-equity incentive plan, $347.7K in salary and $8.1K in other compensation.

2013

In 2013, Mary Kay Fenton earned a total compensation of $989.6K as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals.

Ranking6,559 out of 11,965
Percentile45.2%

Mary Kay Fenton's 2013 compensation ranked 6,559th out of 11,965 executive pay records tracked by us this year.

Fenton earned more than 45.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking497 out of 1,095
Percentile54.6%

In the industry group of Drugs, Fenton's pay ranked 497th out of 1,095 executive pay records tracked by us in 2013.

Fenton earned more than 54.6% of executives in this group.

Non-Equity Incentive Plan$74,256
Option Awards$580,968
Salary$326,400
Other$7,992
Total$989,616

Fenton received $581K in option awards, which accounts for 58.71% of total compensation.

Fenton also received $74.3K in non-equity incentive plan, $326.4K in salary and $8K in other compensation.

2012

In 2012, Mary Kay Fenton earned a total compensation of $1.4M as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals.

Ranking4,780 out of 10,951
Percentile56.4%

Mary Kay Fenton's 2012 compensation ranked 4,780th out of 10,951 executive pay records tracked by us this year.

Fenton earned more than 56.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking250 out of 850
Percentile70.6%

In the industry group of Drugs, Fenton's pay ranked 250th out of 850 executive pay records tracked by us in 2012.

Fenton earned more than 70.6% of executives in this group.

Non-Equity Incentive Plan$138,176
Option Awards$922,084
Salary$300,800
Other$7,833
Total$1,368,893

Fenton received $922.1K in option awards, which accounts for 67.36% of total compensation.

Fenton also received $138.2K in non-equity incentive plan, $300.8K in salary and $7.8K in other compensation.

2011

In 2011, Mary Kay Fenton earned a total compensation of $817.6K as Executive Vice President and Chief Financial Officer at Achillion Pharmaceuticals.

Ranking6,123 out of 10,040
Percentile39.0%

Mary Kay Fenton's 2011 compensation ranked 6,123rd out of 10,040 executive pay records tracked by us this year.

Fenton earned more than 39.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking337 out of 705
Percentile52.2%

In the industry group of Drugs, Fenton's pay ranked 337th out of 705 executive pay records tracked by us in 2011.

Fenton earned more than 52.2% of executives in this group.

Non-Equity Incentive Plan$105,676
Option Awards$416,633
Salary$287,625
Other$7,703
Total$817,637

Fenton received $416.6K in option awards, which accounts for 50.96% of total compensation.

Fenton also received $105.7K in non-equity incentive plan, $287.6K in salary and $7.7K in other compensation.

2010

In 2010, Mary Kay Fenton earned a total compensation of $788.1K as Senior Vice President and Chief Financial Officer at Achillion Pharmaceuticals.

Ranking5,791 out of 9,488
Percentile39.0%

Mary Kay Fenton's 2010 compensation ranked 5,791st out of 9,488 executive pay records tracked by us this year.

Fenton earned more than 39.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking291 out of 619
Percentile53.0%

In the industry group of Drugs, Fenton's pay ranked 291st out of 619 executive pay records tracked by us in 2010.

Fenton earned more than 53.0% of executives in this group.

Non-Equity Incentive Plan$90,406
Option Awards$426,760
Salary$263,222
Other$7,673
Total$788,061

Fenton received $426.8K in option awards, which accounts for 54.15% of total compensation.

Fenton also received $90.4K in non-equity incentive plan, $263.2K in salary and $7.7K in other compensation.

2009

In 2009, Mary Kay Fenton earned a total compensation of $388.1K as Senior Vice President and Chief Financial Officer at Achillion Pharmaceuticals.

Ranking6,891 out of 8,717
Percentile20.9%

Mary Kay Fenton's 2009 compensation ranked 6,891st out of 8,717 executive pay records tracked by us this year.

Fenton earned more than 20.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking444 out of 583
Percentile23.8%

In the industry group of Drugs, Fenton's pay ranked 444th out of 583 executive pay records tracked by us in 2009.

Fenton earned more than 23.8% of executives in this group.

Non-Equity Incentive Plan$70,650
Option Awards$78,138
Salary$235,500
Other$3,826
Total$388,114

Fenton received $235.5K in salary, which accounts for 60.68% of total compensation.

Fenton also received $70.7K in non-equity incentive plan, $78.1K in option awards and $3.8K in other compensation.

2008

In 2008, Mary Kay Fenton earned a total compensation of $285.8K as Senior Vice President and Chief Financial Officer at Achillion Pharmaceuticals.

Ranking6,894 out of 7,751
Percentile11.1%

Mary Kay Fenton's 2008 compensation ranked 6,894th out of 7,751 executive pay records tracked by us this year.

Fenton earned more than 11.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking483 out of 542
Percentile10.9%

In the industry group of Drugs, Fenton's pay ranked 483rd out of 542 executive pay records tracked by us in 2008.

Fenton earned more than 10.9% of executives in this group.

Non-Equity Incentive Plan$37,800
Option Awards$31,401
Salary$210,000
Other$6,581
Total$285,782

Fenton received $210K in salary, which accounts for 73.48% of total compensation.

Fenton also received $37.8K in non-equity incentive plan, $31.4K in option awards and $6.6K in other compensation.